Guggenheim Capital LLC increased its position in Invacare Co. (NYSE:IVC) by 108.4% during the fourth quarter, Holdings Channel reports. The institutional investor owned 303,098 shares of the company’s stock after buying an additional 157,626 shares during the period. Guggenheim Capital LLC’s holdings in Invacare were worth $3,955,000 at the end of the most recent reporting period.
A number of other institutional investors also recently modified their holdings of IVC. Franklin Resources Inc. boosted its position in shares of Invacare by 5.2% in the fourth quarter. Franklin Resources Inc. now owns 349,500 shares of the company’s stock worth $4,561,000 after buying an additional 17,400 shares in the last quarter. Menta Capital LLC boosted its position in shares of Invacare by 69.4% in the fourth quarter. Menta Capital LLC now owns 41,546 shares of the company’s stock worth $542,000 after buying an additional 17,020 shares in the last quarter. AlphaOne Investment Services LLC boosted its position in shares of Invacare by 22.4% in the fourth quarter. AlphaOne Investment Services LLC now owns 338,779 shares of the company’s stock worth $4,421,000 after buying an additional 62,100 shares in the last quarter. Royce & Associates LP boosted its position in shares of Invacare by 17.2% in the fourth quarter. Royce & Associates LP now owns 1,084,730 shares of the company’s stock worth $14,156,000 after buying an additional 158,880 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its position in shares of Invacare by 4.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 2,584,741 shares of the company’s stock worth $33,731,000 after buying an additional 109,451 shares in the last quarter.
Invacare Co. (NYSE:IVC) opened at 12.10 on Tuesday. The stock’s market cap is $392.15 million. The company has a 50-day moving average price of $11.82 and a 200-day moving average price of $11.72. Invacare Co. has a 52 week low of $8.00 and a 52 week high of $14.06.
Invacare (NYSE:IVC) last posted its quarterly earnings data on Thursday, February 9th. The company reported ($0.46) EPS for the quarter, missing analysts’ consensus estimates of ($0.30) by $0.16. The business earned $246.70 million during the quarter, compared to analyst estimates of $262.53 million. Invacare had a negative return on equity of 8.18% and a negative net margin of 4.09%. Invacare’s revenue for the quarter was down 12.9% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.06) EPS. Analysts anticipate that Invacare Co. will post ($1.04) earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, April 13th. Shareholders of record on Monday, April 3rd will be paid a $0.0125 dividend. This represents a $0.05 dividend on an annualized basis and a yield of 0.41%. The ex-dividend date of this dividend is Thursday, March 30th. Invacare’s dividend payout ratio is currently -3.79%.
Separately, Zacks Investment Research cut Invacare from a “hold” rating to a “strong sell” rating in a research note on Friday, January 20th.
Invacare Company Profile
Invacare Corporation is a manufacturer and distributor for medical equipment used in non-acute care settings. The Company’s geographical segments are Europe; North America, which includes North America/Home Medical Equipment (North America/HME) and Institutional Products Group (IPG) segments, and Asia/Pacific.
Want to see what other hedge funds are holding IVC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Invacare Co. (NYSE:IVC).